Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca AbfiledCriticalAstrazeneca Ab
Priority to CU20100057ApriorityCriticalpatent/CU20100057A7/en
Publication of CU20100057A7publicationCriticalpatent/CU20100057A7/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención proporciona compuestos de fórmula (I) en donde n, p, R1, R2, X1, X2, X3, X4, X5, R3a, R3b, R4, R5 y R6 son tal como se definen en la memoria descriptiva, un proceso para su preparación, composiciones farmacéuticas que los contienen y su uso en terapia.The present invention provides compounds of formula (I) wherein n, p, R1, R2, X1, X2, X3, X4, X5, R3a, R3b, R4, R5 and R6 are as defined in the specification, a process for its preparation, pharmaceutical compositions containing them and their use in therapy.
CU20100057A2010-04-022010-04-02
COMPOUNDS [3,2-C] PIRAZOL STEROIDS WITH GLUCOCORTICOID ACTIVITY
CU20100057A7
(en)
Compounds derived from 1-piperazinyl-3-pyridinecarboxylate, as voltage-dependent sodium channel blockers; pharmaceutical composition; and its use for the treatment of respiratory or respiratory tract diseases such as asthma, epoch, cough, silicosis, among others.
Derivatives of estra-1,3,5 (10), 16-tetraen-3-carboxamide, procedures for their preparation, pharmaceutical preparations containing them, as well as their use for the preparation of medicines
Compounds derived from azetidin-2-one; with an inhibitory effect on cholesterol; procedure for preparing the compounds; intermediate compounds; pharmaceutical composition comprising one of the compounds; and use of the compounds in the preparation of drugs.